Category: Antibody Technologies
Global Antibody Technologies
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
... Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the adult ... Read More
-
2023 Global Forecast for Plasma Protein Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2023 Global Antibodies Contract Manufacturing Industry (2029 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total ... Read More
-
Global Cancer Biologics Market Size study & Forecast, by Product (Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, and Immune Checkpoint Inhibitors), by Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030
... Leukemia, Lymphoma, Others), by Distribution Channel (Hospitals, Clinics, and Others) and Regional Analysis, 2023-2030 Global Cancer Biologics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy ... Read More
-
2023 Global Forecast for Pd-1 And Pd-L1 Inhibitors Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
Biopharmaceutical Excipient Manufacturing Market by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers / Surfactants, Polyols, Proteins / Amino Acids and Others, Company Size (Small, Mid-sized, Large / Very Large), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035
... / Very Large), Scale of Operation (Preclinical, Clinical and Commercial) and Key Geographies (North America, Europe, Asia Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2022-2035 Over the years, the rising popularity ... Read More
-
Global Neuromyelitis Optica Spectrum Disorder Market 2023-2027
... on the neuromyelitis optica spectrum disorder market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
... billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the ... Read More
-
Cancer Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 56.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4.1% during 2023-2028. A cancer monoclonal antibody refers to a laboratory-generated molecule that is engineered to mimic the immune system’s attack on cancer ... Read More
-
Global Protein Engineering Market - 2023-2030
... protein engineering market is expected to exhibit a CAGR of 15.2% during the forecast period (2023-2030). Protein engineering is the process of altering or developing proteins in order to improve existing characteristics or add additional ... Read More
-
Global Antibody Drug Conjugates Market - 2023-2030
... 2030. The market is exhibiting at a CAGR of 16.6% during the forecast period (2023-2030). The global antibody drug conjugates market is driven by factors such as the increasing prevalence of cancer, growing investments in ... Read More
-
Global Monoclonal Antibody Therapeutics Market - 2023-2030
... The global monoclonal antibody therapeutics market is expected to exhibit a CAGR of 14.1% during the forecast period (2023-2030). Monoclonal antibody therapeutics (mAbs) are generated from identical antibodies (or simply antibody fragments) in a homogeneous ... Read More
-
Global Peripheral Blood Mononuclear Cells Market Assessment, By Product [Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, PBMC Isolation & Viability Kits], By Application [Immunology, Hematology, Vaccine Development, Toxicology, Infectious Disease, others], By Techniques [Density Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F
... Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F The Global Peripheral Blood Mononuclear Cells (PBMCs) Market is projected to reach USD 273.28 million by 2030 from USD 589.84 million ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028
... reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer ... Read More
-
Global MMP13 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel MMP13 antibody drugs, increasing penetration rate of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ... Read More
-
Global HDAC2 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HDAC2 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in HDAC2 ... Read More
-
Global S100A11 Antibody Market Growth 2023-2029
... % from 2023 to 2029. The growing patient base, the launch of novel S100A11 antibody drugs, the increasing penetration rate of antibody drugs, and the continuous regulation of the entire biopharmaceutical industry are the key ... Read More
-
Global HMGB1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global CD31 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 ... Read More
-
Global C-EBP Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel C/EBP antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of C/EBP ... Read More
-
Global Anti-NeuN Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel anti-neuronal antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global EEA1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel EEA1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global AQP4 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel AQP4 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in AQP4 ... Read More
-
Global HP1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in HP1 ... Read More
Research Assistance
